Christophe Moreno
Université libre de Bruxelles
281 Papers
1.9K Citations
Christophe Moreno is an academic researcher from Université libre de Bruxelles. The author has contributed to research in topics: Medicine & Hepatitis C. The author has an hindex of 53, co-authored 259 publications. Previous affiliations of Christophe Moreno include Free University of Brussels & University of Toronto.
Chat about Author
Papers
Induction of tolerance in solid organ transplantation: the rationale to develop clinical protocols in liver transplantation.
Vincent Donckier,A. Sanchez-Fueyo,Ligia Craciun,Valerio Lucidi,Alexis Buggenhout,Roberto Troisi,Xavier Rogiers,Nadine Bourgeois,Nathalie Boon,Christophe Moreno,Isabelle Colle,H. Van Vlierberghe,B. de Hemptinne,Michel Goldman +13 more
- 01 Mar 2009
TL;DR: Significant efforts must be made to achieve reliable strategies for immunosuppression minimization or withdrawal after organ transplantation into the clinics, particularly in liver transplantation.
8
1357 pentoxifylline does not improve short-term survival in severe alcoholic hepatitis in combination with corticosteroids: results of a randomized controlled trial
Alexandre Louvet,Thong Dao,P. Nahon,Emmanuel Diaz,Nicolas Carbonell,Jérôme Boursier,Rodolphe Anty,Didier Lebrec,Romain Moirand,Dominique Thabut,Christophe Moreno,N. Talbodec,Thierry Paupard,Sylvie Naveau,Christine Silvain,G.-P. Pageaux,Rodolphe Sobesky,J. Salleron,Alain Duhamel,P. Mathurin +19 more
8
Liver transplantation in cases of portal vein thrombosis in the recipient: a case report and review of the various options.
Desislava Germanova,Valerio Lucidi,Alexis Buggenhout,Nathalie Boon,Nadine Bourgeois,Delphine Degré,Thierry Gustot,Christophe Moreno,M.A. Bali,D. Brisbois,Vincent Donckier +10 more
- 01 Nov 2011
TL;DR: A case of liver transplantation in a patient with complete portal vein thrombosis, underlying the potential pitfalls and the risk of intestinal sutures in case of hepaticojejunostomy is reported.
7
Safety of sofosbuvir-based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study.
Rodolphe Anty,Guillaume Favre,Audrey Coilly,Emilie Rossignol,Pauline Houssel-Debry,Christophe Duvoux,V. de Ledinghen,V. Di Martino,Vincent Leroy,S. Radenne,Nassim Kamar,Valérie Canva,L. D’Alteroche,François Durand,Jérôme Dumortier,Pascal Lebray,Camille Besch,Albert Tran,Clémence M. Canivet,Danielle Botta-Fridlund,H. Montialoux,Christophe Moreno,Fabio Conti,Christine Silvain,P. Perré,François Habersetzer,Armando Abergel,Maryline Debette-Gratien,Sébastien Dharancy,Vincent L.M. Esnault,Claire Fougerou-Leurent,Carole Cagnot,Alpha Diallo,Aurelie Veislinger,H. Danjou,Didier Samuel,Georges Philippe Pageaux,Jean Charles Duclos-Vallée +37 more
TL;DR: In liver transplant recipients with hepatitis C virus recurrence, there is concern about renal safety of sofosbuvir‐based regimens, and changes in serum creatinine or in the estimated glomerular filtration rate under treatment are used to look for possible renal toxicity.
7